Finance

U.S. prosecutors consider more charges against ex-CEO Shkreli

Posted on

Martin Shkreli, former CEO of Turing Pharmaceuticals LLC, appears before a House Oversight and Government Reform hearing on Capitol Hill in Washington in this file picture taken February 4, 2016. REUTERS/Joshua Roberts/Files Thomson ReutersFile photo of Shkreli, former CEO of Turing Pharmaceuticals LLC, appearing before a hearing in Washington

NEW YORK (Reuters) – Former drug executive Martin Shkreli, who last year became a lightning rod for outrage over soaring prescription drug prices, may face additional U.S. charges of securities fraud, a federal prosecutor said on Tuesday.

More charges related to Shkreli’s involvement with biopharmaceutical company Retrophin Inc could be filed within a month, Assistant U.S. Attorney Winston Paes said at a hearing in federal court in Brooklyn, New York.

(Reporting by David Ingram; Editing by Nick Zieminski)

Read the original article on Reuters. Copyright 2016. Follow Reuters on Twitter.

Related Items:
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Most Popular

81.3K
Automotive

Comment Of The Day: Truth In Bragging Edition
32.8K
Finance

The world’s most popular migrant routes, in maps
28.5K
Tech

1920+: Alternate history WWI shooter with friggin’ amazing concept art
28.2K
Tech

iPhone 6c specs, price and design revealed in huge new leak
27.6K
Tech

Galaxy S7 edge concept design has us craving the real thing
Sports

The good, the bad, and the unknown in athlete investments
Finance

Amazon poached 30 executives from Microsoft in the past 3 years — 6 times as many executives as the next lead poacher, Google (AMZN)
Automotive

New York Fire Trucks Sound Unhappy About Their One (1) Job
To Top